President Trump issued an Executive Order instructing federal agencies to implement a variety of drug pricing reforms.

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

Both Original Medicare (Part A and Part B) and Medicare Advantage (Part C) provide coverage for: Medicare Part D covers various diabetic supplies, insulin, and antidiabetic drugs. One of the ...

The Centers for Medicare and Medicaid Services recently announced ... The drugs have already received additional indications from the U.S. Food and Drug Administration to lower the risk of heart ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug ...

For a drug to receive Medicare coverage, it must have Food and Drug Administration (FDA) approval, and a Part D plan’s formulary must include the drug. A formulary is a list of covered medications.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Bob Herman covers ...

Juliette Cubanski, the deputy director of the Program on Medicare Policy at KFF ... approvals for biosimilar products is less likely to occur when the US Food and Drug Administration is short on staff ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million Americans on ...